The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate

Human Molecular Genetics

Volumn 9, Issue 11, 2000, Pages 1567-1574

  Scoles, Daniel R ^a   Huynh, Duong P ^a   Chen, Mercy S ^a   Burke, Stephen P ^b   Gutmann, David H ^b   Pulst, Stefan M ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERLIN; PROTEIN TYROSINE KINASE; SCATTER FACTOR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENDOSOME; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LYSOSOME; MISSENSE MUTATION; MOLECULAR CLONING; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHWANN CELL; SIGNAL TRANSDUCTION;

EID: 0034234579     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.11.1567     Document Type: Article

References (42)

1. Mautner, V.F., Lindenau, M., Baser, M.E., Hazim, W., Tatagiba, M., Haase, W., Samii, M., Wais, R. and Pulst, S.M. (1996) The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery, 38, 880-885.
2. Sainz, J., Huynh, D.P., Figueroa, K., Ragge, N.K., Baser, M.E. and Pulst, S.M. (1994) Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum. Mol. Genet., 3, 885-891.
3. Ruttledge, M.H., Sarrazin, J., Rangaratnam, S., Phelan, C.M., Twist, E., Merel, P., Delattre, O., Thomas, G., Nordenskjöld, M. et al. (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet., 6, 180-184.
4. Rubio, M.P., Correa, K.M., Ramesh, V., MacCollin, M.M., Jacoby, L.B., von Deimling, A., Gusella, J.F. and Louis, D.N. (1994) Analysis of the Neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res., 54, 45-47.
5. Gutmann, D.H., Giordano, M.J., Fishback, A.S. and Guha, A. (1997) Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology, 49, 267-270.
6. Huynh, D.P., Mautner, V., Baser, M.E., Stavrou, D. and Pulst, S.M. (1997) Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas. J. Neuropathol. Exp. Neurol., 56, 382-390.
7. Rouleau, G.A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Xuan, K.H., Demczuk, S., Desmaze, C., Plougastel, B. et al. (1993) Alteration in a new gene coding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature, 363, 515-521.
8. Trofatter, J.A., MacCollin, M.M., Rutter, J.L., Murrell, J.R., Duyao, M.P., Parry, D.M., Eldridge, R., Kley, N., Menon, A., Pulaski, K. et al. (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell, 72, 791-800.
9. Gonzalez-Agosti, C., Xu, L., Pinney, D., Beauchamp, R., Hobbs, W., Gusella, J. and Ramesh, V. (1996) The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene, 13, 1239-1247.
10. Scherer, S.S. and Gutmann, D.H. (1996) Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J. Neurosci. Res., 46, 595-605.
11. Pelton, P.D., Sherman, L.S., Rizvi, T.A., Marchionni, M.A., Wood, P., Friedman, R.A. and Ratner, N. (1998) Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells. Oncogene, 17, 195-209.
12. Xu, L., Gonzalez-Agosti, C., Beauchamp, R., Pinney, D., Sterner, C. and Ramesh, V. (1998) Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells. Exp. Cell Res., 238, 231-240.
13. Xu, H.M. and Gutmann, D.H. (1998) Merlin differentially associates with the microtubule and actin cytoskeleton. J. Neurosci. Res., 51, 403-415.
14. Scoles, D.R., Huynh, D.P., Morcos, P.A., Coulsell, E.R., Robinson, N.G.G., Tamanoi, F. and Pulst, S.M. (1998) Neurofibromatosis 2 tumor suppressor schwannomin interacts with βII-spectrin. Nature Genet., 18, 354-359.
15. Huynh, D.P. and Pulst, S.M. (1996) Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. Oncogene, 13, 73-84.
16. Gutmann, D.H., Sherman, L., Seftor, L., Haipek, C., Hoang Lu, K. and Hendrix, M. (1999) Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading. Hum. Mol. Genet., 8, 267-75.
17. Krasnoselsky, A., Massay, M.J., DeFrances, M.C., Michalopoulos, G., Zarnegar, R. and Ratner, N. (1994) Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas. J. Neurosci., 14, 7284-7290.
18. Odorizzi, G., Babst, M. and Emr, S.D. (1998) Fab1p PtdIns (3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell, 95, 847-858.
19. Takeshita, T., Arita, T., Higuchi, M., Asao, H., Endo, K., Kuroda, H., Tanaka, N., Murata, K., Ishii, N. and Sugamura, K. (1997) STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity, 6, 449-457.
20. Asao, H., Sasaki, Y., Arita, T., Tanaka, N., Endo, K., Kasai, H., Takeshita, T., Endo, Y., Fujita, T. and Sugamura, K. (1997) Hrs is associated with STAM, a signal-transducing adaptor molecule: its suppressive effect on cytokine-induced cell growth. J. Biol. Chem., 272, 32785-32791.
21. Fields, S. and Song, O.-k. (1989) A novel genetic system to detect protein-protein interactions. Nature, 340, 245-246.
22. Komada, M. and Kitamura, N. (1995) Growth factor-induced tyrosine phosphorylation of HRS, a novel 115-kilodalton protein with a structurally conserved putative zinc finger domain. Mol. Cell. Biol., 15, 6213-6221.
23. Poullet, P. and Tamanoi, T. (1995) Use of the yeast two-hybrid system to evaluate ras interactions with neurofibromin GTP-ase activating proteins. Methods Enzymol., 255, 488-497.
24. Stenmark, H., Aasland, R., Toh, B.H. and D'Arrigo, A. (1996) Endosomal localization of the autoantigen EEA1 is mediated by a zinc-binding FYVE finger. J. Biol. Chem., 271, 24048-24054.
25. Reczek, D., Berryman, M. and Bretscher, A. (1997) Identification of EBP50: a PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J. Cell Biol., 139, 169-179.
26. Murthy, A., Gonzalez-Agosti, C., Cordera, E., Pinney, D., Candia, C., Solomon, F., Gusella, J. and Ramesh, V. (1998) NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J. Biol. Chem., 273, 1273-1276.
27. Bean, A.J., Seifert, R., Chen, Y.A., Sacks, R. and Scheller, R.H. (1997) HRS-2 is an ATPase implicated in calcium-regulated secretion. Nature, 385, 826-829.
28. Gutmann, D.H., Geist, R.T., Xu, H.-M., Kim, J.S. and Saporito-Irwin, S. (1998) Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum. Mol. Genet., 7, 335-345.
29. Gutmann, D.H., Haipek, C.A. and Hoang, L.K. (1999) Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations. J. Neurosci. Res., 58, 706-716.
30. Komada, M., Masaki, R., Yamamoto, A. and Kitamura, N. (1997) HRS, a tyrosine kinase substrate with a conserved double zinc finger domain, is localized to the cytoplasmic surface of early endosomes. J. Biol. Chem., 272, 20538-20544.
31. McCartney, B.M. and Fehon, R.G. (1996) Distinct cellular and subcellular patterns of expression imply distinct functions for the Drosophila homologues of moesin and the neurofibromatosis 2 tumor suppressor, merlin. J. Cell Biol., 133, 843-852.
32. Burd, C.G. and Emr, S.D. (1999) Phosphatidylinositol(3)-phosphate signaling mediated by specific binding to ring FYVE domains. Mol. Cell, 2, 157-162.
33. Gaullier, J.M., Simonsen, A., D'Arrigo, A., Bremnes, B., Stenmark, H. and Aasland, R. (1998) FYVE fingers bind PtdIns(3)P. Nature, 394, 432-433.
34. Kawahara, A. Minami, Y., Miyazaki, T., Ihle, J.N. and Taniguchi, T. (1995) Critical role of the interleukin 2 (IL-2) receptor γ-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl Acad. Sci. USA, 92, 8724-8728.
35. Watanabe, S., Itoh, T. and Arai, K. (1996) JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. J. Biol. Chem., 271, 12681-12686.
36. Huynh, D.P., Nechiporuk, T. and Pulst, S.M. (1994) Differential expression and tissue distribution of type I and type II neurofibromin during mouse fetal development. Dev. Biol., 161, 538-551.
37. Dahlberg, W.K., Little, J.B., Fletcher, J.A., Suit, H.D. and Okunieff, P. (1993) Radiosensitivity in vitro of human soft tissue carcinoma cell lines and skin fibroblasts derived from the same patients. Int. J. Radiat. Biol., 63, 191-198.
38. Kluwe, L. and Mautner, V.F. (1996) A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2. Hum. Genet., 97, 224-227.
39. Sherman, L., Xu, H.-M., Geist, R.T., Saporito-Irwin, S., Howells, N., Ponta, H., Herrlich, P. and Gutmann, D.H. (1997) Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene, 15, 2505-2509.
40. Irving, R.M., Moffat, D.A., Hardy, D.G., Barton, D.E., Xuereb, J.H. and Maher, E.R. (1994) Somatic NF2 gene mutations in familial and non-familal vestibular schwannoma. Hum. Mol. Genet., 3, 347-350.
41. Merel, P., Hoang-Xuan, K., Sanson, M., Bijlsma, E., Rouleau, G., Laurent-Puig, P., Pulst, S., Baser, M., Lenoir, G., Sterkers, J.M. et al. (1995) Screening for germline mutations in the NF2 gene. Genes Chromosomes Cancer., 12, 117-127.
42. Evans, D.G.R., Bourn, D., Wallace, A., Ramsden, R.T., Mitchell, J.D. and Strachan, T. (1995) Diagnosis issues in a family with late onset type 2 neurofibromatosis. J. Med. Genet., 32, 470-474.